Evidence map›Paper›PMID 35904625›Full record

ArticleWorld journal of microbiology & biotechnology2022

Actinomycin D: a novel Pseudomonas aeruginosa quorum sensing inhibitor from the endophyte Streptomyces cyaneochromogenes RC1.

Yue-Xiang Zeng, Jun-Sheng Liu, Ying-Jie Wang, Shi Tang, Da-Yong Wang, Shi-Ming Deng, Ai-Qun Jia

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Anti-QS Strategies AgainstMicroorganisms · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Assessing the antibacterial potential of 6-gingerol: Combined experimental and computational approaches.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  12. Review
  13. Review
  14. Article
  15. Two cinnamoyl hydroxamates as potential quorum sensing inhibitors againstFrontiers in cellular and infection microbiology · 2024
    Article
  16. Article
  17. Review
  18. Article
  19. Anti-Frontiers in microbiology · 2023
    Article
  20. Bioremediation of quinclorac injury on tobacco by a rhizosphere bacterium.World journal of microbiology & biotechnology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yue-Xiang Zeng *School of Pharmaceutical Sciences, Hainan University, Haikou, 570228, China.
Jun-Sheng Liu *School of Pharmaceutical Sciences, Hainan University, Haikou, 570228, China.
Ying-Jie WangSchool of Pharmaceutical Sciences, Hainan University, Haikou, 570228, China.
Shi TangSchool of Pharmaceutical Sciences, Hainan University, Haikou, 570228, China.
Da-Yong WangSchool of Pharmaceutical Sciences, Hainan University, Haikou, 570228, China.
Shi-Ming DengSchool of Pharmaceutical Sciences, Hainan University, Haikou, 570228, China.
Ai-Qun JiaSchool of Pharmaceutical Sciences, Hainan University, Haikou, 570228, China. ajia@hainanu.edu.cn.
Hainan University · CN

Funding

National Natural Science Foundation of China 82160664Natural Science Foundation of Hainan Province 221CXTD434
6 · The paper itself

Abstract

The infections caused by Pseudomonas aeruginosa are difficult to treat due to its multidrug resistance. A promising strategy for controlling P. aeruginosa infection is targeting the quorum sensing (QS) system. Actinomycin D isolated from the metabolite of endophyte Streptomyces cyaneochromogenes RC1 exhibited good anti-QS activity against P. aeruginosa PAO1. Actinomycin D (50, 100, and 200 μg/mL) significantly inhibited the motility as well as reduced the production of multiple virulence factors including pyocyanin, protease, rhamnolipid, and siderophores. The images of confocal laser scanning microscopy and scanning electron microscopy revealed that the treatment of actinomycin D resulted in a looser and flatter biofilm structure. Real-time quantitative PCR analysis showed that the expression of QS-related genes lasI, rhlI, rhlR, pqsR, pslA, and pilA were downregulated dramatically. The production of QS signaling molecules N-(3-oxododecanoyl)-L-homoserine lactone and N-butanoyl-L-homoserine lactone were also decreased by actinomycin D. These findings suggest that actinomycin D, a potent in vitro anti-virulence agent, is a promising candidate to treat P. aeruginosa infection by interfering with the QS systems.

Indexed as

Quorum SensingStreptomycesAnti-Bacterial AgentsBacterial ProteinsBiofilmsDactinomycinEndophytesPseudomonas aeruginosaVirulence FactorsAnti-Bacterial AgentsBacterial ProteinsDactinomycinVirulence FactorsActinomycin DBiofilmPseudomonas aeruginosaQuorum sensingVirulence factor

Identifiers

PMID35904625
OpenAlexW4288535657

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.